ArticleCommunications medicine2022

Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy.

Jennifer M Knight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.